Pathologic Predictors of Microsatellite Instability in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Identification of microsatellite unstable (MSI-H) colorectal cancers (CRCs) is important not only for the identification of hereditary nonpolyposis colorectal cancer syndrome but also because MSI-H CRCs have a better prognosis and may respond differently to 5-fluorouracil-based chemotherapy. We present 2 nearly equivalent logistic regression models for clinical use that predict microsatellite instability based on the review of 1649 CRCs from patients of all ages collected in a population-based case control study in northern Israel. One hundred ninety-eight of these 1649 tumors demonstrated a high degree of microsatellite instability (12%). Multivariate analysis found that >2 tumor-infiltrating lymphocyte (TIL) cells per high-powered field, the lack of dirty necrosis, the presence of a Crohn-like reaction, right-sided location, any mucinous differentiation (mucinous or focally mucinous) and well or poor differentiation, and age less than 50 were all independent predictors of MSI-H. We developed 2 logistic regression models that differ only by the statistical approach used to analyze the number of TIL cells per high-powered field, where the slightly more accurate (and complex) model uses the log of the total number of TIL cells. The simpler clinical model uses a cut-off of 2>TIL cells per high-powered field. The accuracy of both models is high, with an 85.4% versus 85.0% probability of correctly classifying tumors as MSI-H. By employing the simpler model, pathologists can predict the likelihood of microsatellite instability by compiling the MSI probability score (Table 4 and Fig. 1) from simple histologic and clinical data available during sign-out. Our model shows that approximately 43% of CRCs have a MSI probability score of 1 or less and hence have little likelihood (<3%) of being MSI-H. Although this model is not perfect in predicting microsatellite instability, its use could improve the efficiency of expensive diagnostic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Qualitatively, we found that in many cases there was a histological phenotype known to be associated with either BRAF mutational status or MSI/ dMMR, such as mucinous histology and/or poor differentiation 30,31 .”
From Swarm learning for decentralized artificial intelligence in cancer histopathology (2022) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundBoland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183 · cited 2×
“A reasonable compromise may be to use clinical and histologic features as a guideline in deciding which cases should have additional testing, such as those recommended in the revised Bethesda Guidelines for HNPPC.38 These guidelines state that all CRCs occurring in patients under 50 be tested, and also all CRCs occurr…”
MethodMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundIonov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
International Histological Classification of Tumours
Weller, R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.6.692-d · Cited by 2,042
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Research works printed but not linked: 1
- Krishna, 1996, Histopathologic features associated with microsatellite instability in colorectal carcinomas, (Abstract) Gastroenterology, 110, A546
Cited by
Pan-cancer image-based detection of clinically actionable genetic alterations
Kather, J. N., Heij, L. R., Grabsch, H. I., Loeffler, C., Echle, A., Muti, H. S., Krause, J., Niehues, J. M., Sommer, K. A. J., Bankhead, P., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0087-6 · Cited by 662
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
“For example, tumors with MSI have long been known to be associated with specific patterns, such as a high density of tumor-infiltrating lymphocytes or mucinous differentiation 71,72 .”
BackgroundIs right-sided colon cancer different to left-sided colorectal cancer? – A systematic review
Lee, G. H., Malietzis, G., Askari, A., Bernardo, D., Al-Hassi, H. O., & Clark, S. K. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2014.11.001 · Cited by 421
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
Echle, A., Grabsch, H. I., Quirke, P., van den Brandt, P. A., West, N. P., Hutchins, G. G. A., Heij, L. R., Tan, X., Richman, S. D., Krause, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.021 · Cited by 376
“BSIC ND TRANATIONAL AT manual quantification of these features by experts is not reliable enough for clinical diagnosis and, therefore, is not feasible in routine clinical practice.(15) In contrast, computerbased image analysis by deep learning has enabled robust detection of MSI and dMMR status directly from routine…”
MethodARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
Mathur, R., Alver, B. H., San Roman, A. K., Wilson, B. G., Wang, X., Agoston, A. T., Park, P. J., Shivdasani, R. A., & Roberts, C. W. M. (2017) · Nature Genetics · doi:10.1038/ng.3744 · Cited by 360
“%) in cancers of the MSI type 7–8 , these findings are highly relevant to human disease.”
BackgroundInfluentialBilal, M., Raza, S. E. A., Azam, A., Graham, S., Ilyas, M., Cree, I. A., Snead, D., Minhas, F., & Rajpoot, N. M. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00180-1 · Cited by 299
“Our findings of a strong correlation between microsatellite instability and hypermutation, 1,3,37 a moderate correlation between microsatellite instability and CIMP, 6,7 and a high infiltrate of inflammatory cells in microsatellite instable tumours 9,32,34 are in line with existing literature.”
BackgroundResultIdos, G. E., Kwok, J., Bonthala, N., Kysh, L., Gruber, S. B., & Qu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60255-4 · Cited by 291
Self-citationSwarm learning for decentralized artificial intelligence in cancer histopathology
Saldanha, O. L., Quirke, P., West, N. P., James, J. A., Loughrey, M. B., Grabsch, H. I., Salto-Tellez, M., Alwers, E., Cifci, D., Ghaffari Laleh, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01768-5 · Cited by 227
A guide to artificial intelligence for cancer researchers
Perez-Lopez, R., Ghaffari Laleh, N., Mahmood, F., & Kather, J. N. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00694-7 · Cited by 211
“to known morphological features, which was known even before deep learning 39 .”
Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
Rozek, L. S., Schmit, S. L., Greenson, J. K., Tomsho, L. P., Rennert, H. S., Rennert, G., & Gruber, S. B. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw027 · Cited by 218
“DNA was extracted from tumor slides as previously described (10).”
Self-citationValle, L., Vilar, E., Tavtigian, S. V., & Stoffel, E. M. (2019) · The Journal of Pathology · doi:10.1002/path.5229 · Cited by 203
“In fact, the presence of TILs became a standard pathology criterion for the diagnosis of sporadic and hereditary MSI tumors [126].”
BackgroundSong, H., Srivastava, A., Lee, J., Kim, Y. S., Kim, K., Ki Kang, W., Kim, M., Kim, S., Park, C. K., & Kim, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.002 · Cited by 188
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
Funkhouser, W. K., Lubin, I. M., Monzon, F. A., Zehnbauer, B. A., Evans, J. P., Ogino, S., & Nowak, J. A. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.11.001 · Cited by 189
“Assuming that most of these Colorectal Family Registry data pertained to Lynch syndrome patients, IHC criteria alone would fail to detect 11% to 12% of new Lynch syndrome patients (Table 2).(83,108) Receiver operating characteristic curves show similar areas under the curves for MSI and IHC testing.”
BackgroundInfluentialGhaffari Laleh, N., Muti, H. S., Loeffler, C. M. L., Echle, A., Saldanha, O. L., Mahmood, F., Lu, M. Y., Trautwein, C., Langer, R., Dislich, B., et al. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102474 · Cited by 179
Schirris, Y., Gavves, E., Nederlof, I., Horlings, H. M., & Teuwen, J. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102464 · Cited by 143
“We believe that this is due to the tumor annotations done in TCGA-CRCk, strengthening the supervisory signal for the MSI classification task as most tiles contain tumor tissue that reflects information about the cancer genotype.”
MethodColorectal Cancer Due to Deficiency in DNA Mismatch Repair Function: A Review
Bellizzi, A. M., & Frankel, W. L. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181bb6bdc · Cited by 165
“One practical method involves scanning the slide for a region with TIL, counting 5 consecutive 40 fields, and calculating the mean number of TIL/high-power field (HPF); studies using this method defined a positive result as >2 TIL/HPF.(26,83) Peritumoral lymphocytes refer to the lymphoid cuff at the leading edge of th…”
BackgroundMethodInfluentialVilar, E., Bartnik, C. M., Stenzel, S. L., Raskin, L., Ahn, J., Moreno, V., Mukherjee, B., Iniesta, M. D., Morgan, M. A., Rennert, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1120 · Cited by 150
Self-citationTumor necrosis is a new promising prognostic factor in colorectal cancer
Pollheimer, M. J., Kornprat, P., Lindtner, R. A., Harbaum, L., Schlemmer, A., Rehak, P., & Langner, C. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.04.018 · Cited by 146
“Although previous investigations suggested a relationship between lack of tumor necrosis and lymphocytic infiltration [16–18], we were unable to detect a significant association evaluating the amount of lymphocytes separately in intra- and peritumoral sites.”
BackgroundArtificial intelligence to identify genetic alterations in conventional histopathology
Cifci, D., Foersch, S., & Kather, J. N. (2022) · The Journal of Pathology · doi:10.1002/path.5898 · Cited by 126
“…patterns, speci fi c morphological patterns have been linked to speci fi c genetic alterations in cancer, such as BRAF mutations [11] and microsatellite instability (MSI) in colorectal cancer [12], hormone receptor overexpression in breast cancer [13], and EGFR mutations in lung cancer [14].”
BackgroundSaillard, C., Dubois, R., Tchita, O., Loiseau, N., Garcia, T., Adriansen, A., Carpentier, S., Reyre, J., Enea, D., von Loga, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42453-6 · Cited by 117
Nahhas, O. S. M. E., van Treeck, M., Wölflein, G., Unger, M., Ligero, M., Lenz, T., Wagner, S. J., Hewitt, K. J., Khader, F., Foersch, S., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-01047-2 · Cited by 151
“This cancer type and clinical endpoint were chosen because of their known strong phenotypic-genotypic correlation 15,32,33,55 .”
Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer
Peng, R.-Q. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i19.2428 · Cited by 100
Niehues, J. M., Quirke, P., West, N. P., Grabsch, H. I., van Treeck, M., Schirris, Y., Veldhuizen, G. P., Hutchins, G. G. A., Richman, S. D., Foersch, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100980 · Cited by 100
Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer
Morikawa, T., Kuchiba, A., Qian, Z. R., Mino-Kenudson, M. A., Hornick, J. L., Yamauchi, M., Imamura, Y., Liao, X., Nishihara, R., Meyerhardt, J. A., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2174-5 · Cited by 108
Pei, Q., Yi, X., Chen, C., Pang, P., Fu, Y. H. H., Lei, G., Chen, C., Tan, F., Gong, G., Li, Q., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08167-3 · Cited by 96
“Previous studies have reported that CRC tumors with MSI-H tend to be well or poorly differentiated, being mucinous, having increased tumor-infiltrating lymphocytes, having a circumscribed or expansile growth pattern, showing histologic heterogeneity, and having a prominent Crohn-like reaction at the advancing edge of…”
BackgroundPrognostic stratification of colorectal cancer patients: current perspectives
Langner, C., & Schneider, N. (2014) · Cancer Management and Research · doi:10.2147/cmar.s38827 · Cited by 86
Kim, J.-Y., Shin, N. R., Kim, A., Lee, H., Park, W.-Y., Kim, J.-Y., Lee, C. H., Huh, G. Y., & Park, D. Y. (2013) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2013.47.1.28 · Cited by 91
“Histopathologic findings such as poor differentiation, mucinous histology, right-sided location, increased tumor-infiltrating lymphocytes (TILs), and prominent lymphoid aggregates at the advancing edge (Crohn’s-like reaction) are also commonly used to predict MSI-H in colorectal cancers.(9-11) In contrast to MSI-H col…”
BackgroundLasota, J. P., Chłopek, M., Lamoureux, J., Christiansen, J., Kowalik, A., Wasąg, B., Felisiak-Gołąbek, A., Agaimy, A., Biernat, W., Canzonieri, V., et al. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001377 · Cited by 98
Hildebrand, L. A., Pierce, C. J., Dennis, M., Paracha, M., & Maoz, A. (2021) · Cancers · doi:10.3390/cancers13030391 · Cited by 89
“Using a scoring system incorporating age, anatomical site of the primary tumor, histologic type, tumor grade, and the presence or absence of TILs and CLR, an AUC of 0.89 was achieved when the model was tested against a separate validation cohort (Table 1).”
BackgroundInfluentialClinical implications of microsatellite instability in sporadic colon cancers
Sinicrope, F. A., & Sargent, D. J. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832c94bd · Cited by 90
Liu, X., Goldblum, J. R., Zhao, Z., Landau, M. S., Heald, B., Pai, R. K., & Lin, J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318253645a · Cited by 92
Era of universal testing of microsatellite instability in colorectal cancer
Zhang, X., & Li, J. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i2.12 · Cited by 99
Lee, S. H., Song, I. H., & Jang, H. (2021) · International Journal of Cancer · doi:10.1002/ijc.33599 · Cited by 88
“Tumors were assessed for the presence or absence of characteristic necrotic debris, so-called “dirty necrosis,” which is often suggestive of a characteristic of CRC.9”
BackgroundMethodInfluentialMei, W.-J., Mi, M., Qian, J., Xiao, N., Yuan, Y., & Ding, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019582 · Cited by 95
Schrammen, P. L., Ghaffari Laleh, N., Echle, A., Truhn, D., Schulz, V., Brinker, T. J., Brenner, H., Chang‐Claude, J., Alwers, E., Brobeil, A., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5800 · Cited by 80
“MSI, as determined by polymerase chain reaction (PCR), and dMMR, as determined by immunohistochemistry (IHC), are used interchangeably in most clinical situations, although the results of these different tests are not always concordant [3,5].”
BackgroundShao, J., Ma, J., Zhang, Q., Li, W., & Wang, C. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.006 · Cited by 90
Differential colorectal carcinogenesis: Molecular basis and clinical relevance
Morán, A., Ortega, P., de Juan, C., Fernández‐Marcelo, T., Frías, C., Sánchez-Pernaute, A., Torres, A. J., Díaz-Rubio, E., Iniesta, P., & Benito, M. (2010) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v2.i3.151 · Cited by 128
Park, J. H., Powell, A. G. M. T., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Edwards, J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.17 · Cited by 86
“…an exponential rate, in particular within repeating microsatellite regions, and are characterised by the presence of MSI as well as distinct phenotypic characteristics, such as proximal tumour location and poor or mucinous differentiation (Ward et al, 2001; Jass et al, 2002; Greenson et al, 2009).”
BackgroundRyan, P., Mulligan, A. M., Aronson, M. D., Ferguson, S. E., Bapat, B. V., Semotiuk, K., Holter, S., Kwon, J. S., Kalloger, S. E., Gilks, C. B., et al. (2011) · Cancer · doi:10.1002/cncr.26323 · Cited by 78
“Analogous to microsatellite-unstable CRC, characteristic histologic features have been proposed to identify LS-EC and EC with an MSI phenotype.(16,17) Peritumoral lymphocytes, TILs (40 in 10 HPF), and tumor heterogeneity reportedly are independent predictors of MSI in patients with endometrioid EC.”
BackgroundBrockmoeller, S., Echle, A., Ghaffari Laleh, N., Eiholm, S., Malmstrøm, M. L., Plato Kuhlmann, T., Levic, K., Grabsch, H. I., West, N. P., Saldanha, O. L., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5831 · Cited by 78
“Again, dMMR was used as a positive control because the histopathological patterns associated with MSI/dMMR are known [43].”
MethodPoorly Differentiated Colorectal Cancers
Xiao, H., Yoon, Y. S., Hong, S., Roh, S. A., Cho, D., Yu, C. S., & Kim, J. C. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcp8p2dynkgrbvi · Cited by 71
Kreidieh, M., Mukherji, D., Temraz, S. N., & Shamseddine, A. I. (2020) · BioMed Research International · doi:10.1155/2020/9037217 · Cited by 80
Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer
Rozek, L. S., Herron, C. M., Greenson, J. K., Moreno, V. R., Capellá, G., Rennert, G., & Gruber, S. B. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1112 · Cited by 70
“However, the number of tumorinfiltrating lymphocytes per high-powered field was similar withinMSI grouping regardless of BRAFmutation status, shown to be a powerful pathologic predictor of MSI-high in this study population (29).”
BackgroundSelf-citationLing, Y., Chen, J., Wen, S., Huang, C., Li, P., Lu, L., Mei, J., Li, S., Wei, W., Cai, M., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07097-5 · Cited by 66
Objective Criteria for Crohn-like Lymphoid Reaction in Colorectal Cancer
Ueno, H., Hashiguchi, Y., Shimazaki, H., Shinto, E., Kajiwara, Y., Nakanishi, K., Kato, K., Maekawa, K., Miyai, K., Nakamura, T., et al. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpwhueftgbwke4 · Cited by 69
Hampel, H. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0044 · Cited by 64
Zaanan, A., Meunier, K., Sangar, F., Fléjou, J., & Praz, F. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0024-x · Cited by 73
“MSI tumours are characterized by strong tumour lymphocyte infiltration [131], a criterion that has recently been proposed as a marker to more accurately predict MSI in CRCs [68].”
BackgroundMaoz, A., Dennis, M. J., & Greenson, J. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01884 · Cited by 72
“Tumors that are deficient in the DNA mismatch repair system (dMMR), leading to microsatellite instability (MSI-H) and a high mutational burden, are associated with the presence and density of CLR (1, 2, 12, 21).”
BackgroundSelf-citationMucinous differentiation in colorectal cancer – indicator of poor prognosis?
Langner, C., Harbaum, L., Pollheimer, M. J., Kornprat, P., Lindtner, R. A., Schlemmer, A., Vieth, M. W., & Rehak, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04155.x · Cited by 60
Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
Zhang, C., Lv, J., Gong, L., Yu, L., Chen, X., Zhou, H., & Fan, L. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13090892 · Cited by 69
“Clinicopathological features of dMMR tumors [16–20].”
Nivolumab in the Treatment of Microsatellite Instability High Metastatic Colorectal Cancer
Sarshekeh, A. M., Overman, M. J., & Kopetz, S. (2018) · Future Oncology · doi:10.2217/fon-2017-0696 · Cited by 60
Ye, J., Zhou, Y., Weiser, M. R., Gönen, M., Zhang, L., Samdani, T., Bacares, R., DeLair, D. F., Ivelja, S., Vakiani, E., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.007 · Cited by 57
“In general, although medullary carcinomas are morphologically similar to poorly differentiated/undifferentiated adenocarcinoma, they are associated with lymphocytic infiltration and frequently associated with MSI [17,18].”
BackgroundJiang, W., Shadrach, B. L., Carver, P. D., Goldblum, J. R., Shen, B., & Liu, X. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825fa4b4 · Cited by 55
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Pavelescu, L. A., Enache, R. M., Roşu, O. A., Profir, M., Creţoiu, S. M., & Gașpar, B. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179659 · Cited by 64
Conesa‐Zamora, P., García‐Solano, J., Garcia‐García, F., Turpín, M. C., Trujillo‐Santos, J., Torres‐Moreno, D., Oviedo-Ramírez, I., Carbonell‐Muñoz, R., Muñoz‐Delgado, E., Rodríguez-Braun, E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27674 · Cited by 55
Signet ring cell component predicts aggressive behaviour in colorectal mucinous adenocarcinoma
Song, I. H., Hong, S., Yu, E., Yoon, Y. S., Park, I. J., Lim, S., Kim, J. C., Yu, C. S., & Kim, J. (2019) · Pathology · doi:10.1016/j.pathol.2019.03.001 · Cited by 55
Karahan, B., Argon, A., Yıldırım, M., & Vardar, E. (2015) · Europe PMC (PubMed Central) · Cited by 52
Microsatellite instability in colorectal cancer: clinicopathological significance
Setaffy, L., & Langner, C. (2015) · Polish Journal of Pathology · doi:10.5114/pjp.2015.54953 · Cited by 51
“[77] presented two nearly equivalent logistic regression models that predict MSI-H status based on a review of 1649 CRCs from patients of all ages collected in a population-based case control study in northern Israel.”
BackgroundMethodInfluentialHeterogeneity of colon cancer: from bench to bedside
Merlano, M. C., Granetto, C., Fea, E., Ricci, V., & Garrone, O. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000218 · Cited by 56
Fountzilas, E., Kotoula, V., Pentheroudakis, G. E., Manousou, K., Polychronidou, G., Vrettou, E., Poulios, C., Papadopoulou, E., Raptou, G., Pectasides, E., et al. (2019) · ESMO Open · doi:10.1136/esmoopen-2018-000474 · Cited by 58
“This association has been well described in previous studies.(50) Similarly, compared with MMR proficiency, MMR deficiency was observed in a higher number of stage I/II endometrial tumours.”
The role of the gut microbiome in colorectal cancer: Where are we? Where are we going?
Wieczorska, K., Stolarek, M., & Stec, R. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.07.006 · Cited by 50
Echle, A., Laleh, N. G., Schrammen, P. L., West, N. P., Trautwein, C., Brinker, T. J., Gruber, S. B., Buelow, R. D., Boor, P., Grabsch, H. I., et al. (2021) · ImmunoInformatics · doi:10.1016/j.immuno.2021.100008 · Cited by 48
Self-citationYan, R., Shen, Y., Zhang, X., Xu, P., Wang, J., Li, J., Ren, F., Ye, D., & Zhou, S. K. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102824 · Cited by 54
Xiao, B., Zhang, X., Cao, T., Li, D., Wu, J., Kong, L.-H., Tang, J., Han, K., Zhang, C.-Z., Mei, W.-J., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7060 · Cited by 48
A Histology-Based Model for Predicting Microsatellite Instability in Colorectal Cancers
Hyde, A. J., Fontaine, D., Stuckless, S. N., Green, R., Pollett, A. F., Simms, M., Sipahimalani, P., Parfrey, P. S., & Younghusband, B. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f6a912 · Cited by 46
“Others have reported similar findings.(13) Crohn-like lymphocytic reaction is another feature that was not statistically significant in discriminating MSI and microsatellite stable tumors in our cohort.”
ResultAlam, R., Abdul‐Ghafar, J., Yim, K., Thakur, N., Lee, S. H., Jang, H., Jung, C. K., & Chong, Y. (2022) · Cancers · doi:10.3390/cancers14112590 · Cited by 50
“To overcome these limitations, researchers started to develop AI models that can predict MSI status using the WSIs from many cancers [29,46,47].”
BackgroundLynch Syndrome Presenting as Endometrial Cancer
Tafe, L. J., Riggs, E. R., & Tsongalis, G. J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206888 · Cited by 49
Rössler, O., Betge, J., Harbaum, L., Mrak, K., Tschmelitsch, J., & Langner, C. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.227 · Cited by 46
Hashmi, A. A., Ali, R. S., Hussain, Z. F., Faridi, N., Khan, E. Y., Bakar, S. M. A., Edhi, M. M., & Khan, M. A. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1158-8 · Cited by 45
“, TILs can correctly classify tumors as MSI-H with approximately 85% probability [26].”
BackgroundDeep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review
Couture, H. D. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12122022 · Cited by 49
“Colorectal cancer microsatellite instability (MSI) can be predicted by tissue characteristics like the presence of tumor infiltrating lymphocytes [4,5].”
BackgroundMorrison, J., Bronner, M. P., Heald, B., Downs-Kelly, E. P., Goldblum, J. R., & Liu, X. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.610003 · Cited by 45
“01 to 92%) [11,13].”
BackgroundCushman-Vokoun, A. M., Stover, D. G., Zhao, Z., Koehler, E. A., Berlin, J. D., & Vnencak-Jones, C. L. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.04.005 · Cited by 24
AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?
Çifçi, D., Veldhuizen, G. P., Foersch, S., & Kather, J. N. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061521-092038 · Cited by 54
Marginean, E. C., & Melosky, B. L. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0040-ra · Cited by 40
Guo, B., Li, X., Yang, M., Jonnagaddala, J., Zhang, H., & Xu, S. X. (2023) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.312 · Cited by 44
“These findings were consistent with the pathological characteristics of MSI-high or MSS samples 25,26 , suggesting that coupling Swin-T with the Grad-CAM algorithm 24 could further improve the interpretability of the model and detect the areas or cells within tiles that have great potential to aid…”
Lynch or Not Lynch? Is that Always a Question?
Colas, C., Coulet, F., Svrcek, M., Collura, A., Fléjou, J., Duval, A., & Hamelin, R. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394280-7.00004-x · Cited by 42
(Re) Defining the High-Power Field for Digital Pathology
Kim, D., Pantanowitz, L., Schüffler, P. J., Yarlagadda, D. V. K., Ardon, O., Reuter, V. E., Hameed, M., Klimstra, D. S., & Hanna, M. G. (2020) · Journal of Pathology Informatics · doi:10.4103/jpi.jpi_48_20 · Cited by 42
Self supervised learning improves dMMR/MSI detection from histology slides across multiple cancersPreprint
Saillard, C., Dehaene, O., Marchand, T., Moindrot, O., Kamoun, A., Schmauch, B., & Jégou, S. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2109.05819 · Cited by 57
“Expert models Several histology patterns on H&E images have been reported to correlate with MSI, such as tumor-infiltrating lymphocytes, lack of dirty necrosis or poor differentiation [(Greenson et al. (2009)].”
BackgroundMethodInfluentialYang, S., Gedvilaite, E., Ptashkin, R. N., Chang, J. C., Ziegler, J., Mata, D. A., Villafania, L. B., Nafa, K., Hechtman, J. F., Benayed, R., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.10.004 · Cited by 47
Park, J. H., Kim, E. Y., Luchini, C., Eccher, A., Tizaoui, K., Shin, J. I., & Lim, B. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052462 · Cited by 42
“Some studies focused on colorectal cancer reported that MSI/dMMR tumors have peculiar histomorphological features (e.g., mucinous, signet-ring or medullary morphology, poor differentiation, tumor infiltrating lymphocytes, peritumoral lymphoid reaction, Crohn’s-like lymphoid reaction, signet ring cells) and clinical fi…”
BackgroundResultMolecular Testing of Solid Tumors
Igbokwe, A., & Lopez-Terrada, D. H. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0413-rar.1 · Cited by 41
Gustav, M., Reitsam, N. G., Carrero, Z. I., Loeffler, C. M. L., van Treeck, M., Yuan, T., West, N. P., Quirke, P., Brinker, T. J., Brenner, H., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00592-z · Cited by 43
“Our hypothesis is grounded on research showing that tumors characterized by MSI, and those with pathogenic POLE / POLD1 mutations (but MSS), exhibit shared clinical and morphological characteristics 20,26 – 29 .”
BackgroundSamowitz, W. S. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.127 · Cited by 38
Hanke, T., Melling, N., Simon, R., Sauter, G., Bokemeyer, C., Lebok, P., Terracciano, L., Izbicki, J. R., & Marx, A. H. (2015) · PubMed · Cited by 36
Lasota, J. P., Chłopek, M., Wasąg, B., Kowalik, A., Christiansen, J., Lamoureux, J., Kuźniacka, A., Felisiak-Gołąbek, A., Liu, Y., Reyes, T. A. R., et al. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001512 · Cited by 38
Artificial intelligence for solid tumour diagnosis in digital pathology
Klein, C., Zeng, Q., Arbaretaz, F., Devêvre, E., Caldéraro, J., Loménie, N., & Maiuri, M. C. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15633 · Cited by 41
“On the other hand, genetic alterations cause functional changes which can induce subtle morphological alterations of the tumour cells morphology (Greenson et al., 2009; Shia et al., 2017).”
BackgroundZhou, J., Belov, L., Huang, P., Shin, J., Solomon, M. J., Chapuis, P. H., Bokey, L., Chan, C., Clarke, C. J., Clarke, S. J., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.01.015 · Cited by 33
“improved prognosis, and increased risk of developing metachronous tumours (Duffy et al., 2007; Greenson et al., 2009).”
BackgroundMicrosatellite Instability Is Common in Colorectal Cancer in Native Nigerians
Irabor, D., Oluwasola, O., Ogunbiyi, O. J., Ogun, G. O., Okolo, C. A., Melas, M., Gruber, S. B., Shi, C., & Raskin, L. (2017) · Anticancer Research · doi:10.21873/anticanres.11612 · Cited by 33
Self-citationSingh, H., Li, Y. Y., Spurr, L. F., Shinagare, A. B., Abhyankar, R., Reilly, E., Brais, L. K., Nag, A., Ducar, M. D., Thorner, A. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4073 · Cited by 35
“In agreement with the known pathologic features of MMR-D colorectal cancer, none of the cancers had conventional moderately differentiated morphology (41).”
ResultAcosta‐Gonzalez, G., Ouseph, M. M., Lombardo, K. A., Lu, S., Glickman, J. N., & Resnick, M. B. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.08.020 · Cited by 34
Marx, A. H., Mickler, C., Sauter, G., Simon, R., Terracciano, L., Izbicki, J. R., & Clauditz, T. S. (2019) · International Journal of Colorectal Disease · doi:10.1007/s00384-019-03478-w · Cited by 39
Saleh, R., Nair, V. S., Toor, S. M., Taha, R. Z., Murshed, K., Al‐Dhaheri, M., Khawar, M., Petkar, M. A., Nada, M. A., Al‐Ejeh, F., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001294 · Cited by 38
“5 6 10–12 Indeed, it has been reported that non-metastatic tumors with MSI phenotype exhibit a higher density of CD8 + T cells, compared with non-MSI phenotype, and that CD8 + T cell density is an independent prognostic indicator for favorable disease-free survival.”
Immunohistochemistry of colorectal carcinoma: current practice and evolving applications
Taliano, R., LeGolvan, M. P., & Resnick, M. B. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.04.017 · Cited by 37
“2A) [50].”
BackgroundKim, J. H., Kim, K.-J., Bae, J. M., Rhee, Y.-Y., Cho, N., Lee, H. S., & Kang, G. H. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202603 · Cited by 32
de Jong, R. A., Boerma, A., Boezen, H. M., Mourits, M. J. E., Hollema, H., & Nijman, H. W. (2012) · International Journal of Cancer · doi:10.1002/ijc.27449 · Cited by 31
“Tumors with abnormal MMR function are believed to be more competent at elicitating an immune response as compared to tumors with a normal MMR system(31) as was demonstrated in colorectal carcinoma.(7,9,10) Similar results were shown in a study among endometrioid EC where the number of TIL and peritumoral lymphocytes w…”
ResultLiao, X., Li, G., McBride, R. B., Houldsworth, J., Harpaz, N., & Polydorides, A. D. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz135 · Cited by 31
Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases
Qin, J., Upadhyay, V. A., Prabhakar, B. S., & Maker, A. V. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-70 · Cited by 29
“TIL quantification was performed according to our standard clinical pathology protocol for primary colon cancers and CRLM, as has previously been reported and is utilized by many groups [16-18].”
MethodIsmael, N. E. H. S., Sheikh, S. A. E., Talaat, S. M., & Salem, E. M. (2017) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2017.003 · Cited by 28
“[24] Young age, right colon, high grade and mucinous differentiation Huang et al.”
BackgroundInfluentialHereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing
Spoto, C. P. E., Gullo, I., Carneiro, F., Montgomery, E. A., & Brosens, L. A. A. (2018) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2018.01.004 · Cited by 28
“Tumor in fi ltrating lymphocytes (TILs) and peritumoral lymphocytes are often present in LSCRC. 61 – 64 Gastric adenocarcinoma in Lynch syndrome can arise anywhere in the stomach and is typically of intestinal type with tubular or di ff use architecture.”
Outcomes of Chemotherapy for Microsatellite Instable–High Metastatic Colorectal Cancers
Shulman, K., Barnett‐Griness, O., Friedman, V., Greenson, J. K., Gruber, S. B., Lejbkowicz, F., & Rennert, G. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00253 · Cited by 30
Self-citation
Metadata
- Authors
- Greenson, J. K., Huang, S.-C., Herron, C., Moreno, V., Bonner, J. D., Tomsho, L. P., Ben-Izhak, O., Cohen, H. I., Trougouboff, P., Bejhar, J., Sova, Y., Pinchev, M., Rennert, G., & Gruber, S. B.
- Affiliations
- Michigan Medicine (US)
- Institut Català d'Oncologia (ES)
- Western Galilee Hospital (IL)
- Emek Medical Center (IL)
- Bnai Zion Medical Center (IL)
- Corresponding author
- Greenson, Joel K.
- Sova, Yanina
- Venue
- American Journal of Surgical Pathology
- Published
- 2009-01
- Volume
- 33
- Issue
- 1
- Pages
- 126-133
- ISSN
- 0147-5185 (ISSN-L)
- PMC
- PMC3500028
- OpenAlex
- W2055732173
- Cited by
- 286
- References
- 43
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 30 · 2022: 31 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 15 · 2014: 11 · 2013: 18 · 2012: 19
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA081488)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, MSI-H colorectal cancer, Lynch syndrome, tumor-infiltrating lymphocytes, mucinous differentiation, tumor location, tumor differentiation, logistic regression prediction model
- MeSH terms
- Adenocarcinoma, Adult, Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Regression Analysis, ROC Curve, Sensitivity and Specificity, Colorectal Neoplasms, Lymphocytes, Tumor-Infiltrating, Area Under Curve, Reverse Transcriptase Polymerase Chain Reaction, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.